Skip to main content

Virco Lab to Market SmartGene's HIV Platform

NEW YORK (GenomeWeb News) – HIV resistance testing company Virco Lab will market SmartGene's web-based data management module to HIV researchers.

The SmartGene HIV platform will enable researchers to use both the SmartGene and Virco services to send an order for sequence data interpretation, and then to store the HIV-1resistance reports within their SmartGene database.

Virco will market the SmartGene HIV module as an integrated data management solution that encompasses various interpretation algorithms, multiple genetic targets, and cumulative resistance reporting, SmartGene said.

David Ellis, president of SmartGene, said in a statement that the HIV platform is ideal for researchers seeking to analyze new genetic targets for resistance.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.